Previous close | 2.8100 |
Open | 2.9600 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 2.8600 - 2.9600 |
52-week range | 1.4000 - 3.5000 |
Volume | |
Avg. volume | 623 |
Market cap | N/A |
Beta (5Y monthly) | -1.26 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 09 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript February 14, 2024 Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.25. Aytu BioPharma, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to the […]
Aytu BioPharma ( NASDAQ:AYTU ) Second Quarter 2024 Results Key Financial Results Revenue: US$22.9m (down 13% from 2Q...